8 Results for "

SIRT6 activator

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "SIRT6 activator" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-115453
CAS No.: 358721-70-7
Purity:  98.88%
Target:  

Sirtuin Autophagy

Research Areas:  

Cancer

UBCS039 is the first synthetic, specific Sirtuin 6 (SIRT6) activator, inducing autophagy in human tumor cells, with an EC50 of 38 μM .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-N0010
CAS No.: 27741-01-1
Geniposidic acid is an orally active FXR modulator and SIRT6 activator. Geniposidic acid binds to the Ser332 and His447 sites on the FXR ligand-binding domain, thereby driving nuclear translocation, coactivator recruitment, and transcription of downstream bile acid and cholesterol metabolism-related genes. Geniposidic acid improves metabolic dysfunction-related fatty liver disease by activating the SIRT6 signaling pathway. Geniposidic acid inhibits inflammation and modulates gut microbiota to alleviate colitis. Geniposidic acid can be used in research on drug-induced liver injury, inflammatory bowel disease, metabolic dysfunction-related fatty liver disease, and metabolic dysfunction-related steatohepatitis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-119376
CAS No.: 2275619-53-7
Purity:  99.11%
Target:  

Sirtuin

Research Areas:  

Cancer

MDL-800 is an allosteric and selective SIRT6 activator. MDL-800 increases SIRT6 deacetylation activity with an EC50 of 10.3 µM .
loading...
    loading...
Cat. No.: HY-148712
CAS No.: 2601734-99-8
Purity:  98.01%
Target:  

Apoptosis Sirtuin

Research Areas:  

Cancer

SIRT6 activator 12q is potent, selective and orally active SIRT6 activator with IC50 values of 171.20, >200, >200, >200, 0.58 μM for SIRT1, SIRT2, SIRT3, SIRT5, SIRT6, respectively. SIRT6 activator 12q inhibits cell growth and migration. SIRT6 activator 12q induces Apoptosis and cell cycle arrest at G2 phase. SIRT6 activator 12q shows anticancer activity .
loading...
    loading...
Cat. No.: HY-156757
CAS No.: 2275619-98-0
Purity:  99.68%
MDL-811 is a selective allosteric activator of SIRT6 with an EC50 of 5.7 μM. MDL-811 possesses anti-inflammatory, antitumor, and neuroprotective activities. MDL-811 can be used for the research of diseases such as colorectal cancer and ischemic stroke .
loading...
    loading...
Cat. No.: HY-169159
CAS No.: 2867630-96-2
Target:  

Sirtuin

Research Areas:  

Metabolic Disease

SIRT6 activator 2 (compound 31) is a sirtuin 6 activator with anti-lipid accumulation properties. SIRT6 activator 2 significantly downregulates LXR, SREBP-1c, and their target genes associated with lipogenesis, and can be used for research related to lipid metabolism-related diseases .
loading...
    loading...
Cat. No.: HY-182061
Target:  

Sirtuin

Research Areas:  

Cancer

SIRT6 activator 3 (Compound 24) is a SIRT6 activator with an EC50 of 5 μM. SIRT6 activator 3 exhibits histone deacetylation activity. SIRT6 activator 3 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-169846
CAS No.: 2488745-53-3
Target:  

Sirtuin

Research Areas:  

Metabolic Disease

CL5D is an activator of protein deacetylase SIRT6. CL5D can significantly enhance the deacetylation activity of SIRT6 and improve its catalytic efficiency. CL5D regulates SIRT6 activity by promoting conformational changes, especially dependent on the role of Arg-65 residue. CL5D can be used to study the activation mechanism of SIRT6 and its function in metabolism, DNA repair and aging .
loading...
    loading...